{"transactions":[{"id":967573,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Stock Appreciation Rights","published_at":"2025-12-16T09:28:48.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":828000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026."}],"balance_after":828000,"derivative":{"exercise_price":4.06,"exercise_date":"2026-03-12","expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":828000},"source":{"system":"sec-edgar","filing":"0001213900-25-121968","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390025121968/ownership.xml","form_type":"4"}},{"id":1005794,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-06T07:30:02.000Z","date":"2025-11-05","kind":"purchase","planned":false,"acquired":true,"shares":90000,"price":2.2,"value":198000.0,"ownership":{"direct":true},"balance_after":502295,"source":{"system":"sec-edgar","filing":"0001213900-25-106835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390025106835/ownership.xml","form_type":"4"}},{"id":1099247,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-30T19:27:46.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 16 equal quarterly installments commencing on September 26, 2025."}],"balance_after":400000,"derivative":{"exercise_price":0.67,"exercise_date":"2025-09-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-25-059864","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390025059864/ownership.xml","form_type":"4"}},{"id":1140426,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-05-20T18:03:44.000Z","date":"2025-05-16","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":0.4303,"value":86060.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Purchase prices range from $0.4071 to $0.4498 per share, inclusive."}],"balance_after":412295,"source":{"system":"sec-edgar","filing":"0001213900-25-046088","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390025046088/ownership.xml","form_type":"4"}},{"id":1409756,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T17:46:26.000Z","date":"2024-09-09","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.59,"value":64750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Purchase prices range from $2.50 to $2.64 per share, inclusive."}],"balance_after":212295,"source":{"system":"sec-edgar","filing":"0001213900-24-077791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390024077791/ownership.xml","form_type":"4"}},{"id":1499135,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-29T21:24:40.000Z","date":"2024-05-24","kind":"other","planned":false,"acquired":false,"shares":43700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer."}],"balance_after":65672,"derivative":{"exercise_price":2.48,"exercise_date":"2024-03-15","expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":43700},"source":{"system":"sec-edgar","filing":"0001213900-24-047637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390024047637/ownership.xml","form_type":"4"}},{"id":1499134,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-29T21:24:40.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":43700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the \"December Award\"), the Reporting Person became entitled to receive options for up to 43,700 additional shares of the Issuer's Common Stock on the same terms as the December Award (the \"Additional Award Shares\") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the \"Plan\"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares."}],"balance_after":109372,"derivative":{"exercise_price":2.48,"exercise_date":"2024-03-15","expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":43700},"source":{"system":"sec-edgar","filing":"0001213900-24-047637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390024047637/ownership.xml","form_type":"4"}},{"id":1704870,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-19T17:28:09.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":65672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 15, 2024."}],"balance_after":65672,"derivative":{"exercise_price":2.48,"exercise_date":"2024-03-15","expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":65672},"source":{"system":"sec-edgar","filing":"0001213900-23-097029","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390023097029/ownership.xml","form_type":"4"}},{"id":1874845,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T17:08:31.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":92958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the \"Plan\"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 equal quarterly installments commencing on March 16, 2023."}],"balance_after":150000,"derivative":{"exercise_price":3.37,"exercise_date":"2023-03-16","expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":92958},"source":{"system":"sec-edgar","filing":"0001213900-23-044087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390023044087/ownership.xml","form_type":"4"}},{"id":2036099,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T17:00:59.000Z","date":"2021-07-08","kind":"gift","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of stock options to family members and a family trust. An independent trustee is trustee of the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options were granted on January 7, 2021. 6.25% of the options vest each quarter from the date of grant."}],"balance_after":132000,"derivative":{"exercise_price":33.43,"expiration_date":"2031-01-07","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001213900-23-007438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390023007438/ownership.xml","form_type":"5"}},{"id":2036098,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T17:00:59.000Z","date":"2021-07-08","kind":"gift","acquired":false,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of stock options to family members and a family trust. An independent trustee is trustee of the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options were granted on December 19, 2019. 6.25% of the options vest each quarter from the date of grant."}],"balance_after":94000,"derivative":{"exercise_price":43.47,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001213900-23-007438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390023007438/ownership.xml","form_type":"5"}},{"id":2036097,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T17:00:59.000Z","date":"2021-07-08","kind":"gift","acquired":false,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of stock options to family members and a family trust. An independent trustee is trustee of the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted on July 29, 2019. 6.25% of the options vest each quarter from the date of grant."}],"balance_after":130400,"derivative":{"exercise_price":8.8,"expiration_date":"2029-07-29","underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0001213900-23-007438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390023007438/ownership.xml","form_type":"5"}},{"id":2036096,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T17:00:59.000Z","date":"2021-07-08","kind":"gift","acquired":false,"shares":6400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of stock options to family members and a family trust. An independent trustee is trustee of the trust."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted on November 12, 2015. 25% of the options vested one year from the grant date and the remaining 75% of the options vested in equal quarterly increments of 6.25% of the initial option grant over the following three year period."}],"balance_after":41,"derivative":{"exercise_price":13.8,"expiration_date":"2025-11-12","underlying":"Common Stock","underlying_shares":4800},"source":{"system":"sec-edgar","filing":"0001213900-23-007438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390023007438/ownership.xml","form_type":"5"}},{"id":2079793,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-12-20T17:32:40.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":57042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 16, 2023."}],"balance_after":57042,"derivative":{"exercise_price":3.37,"exercise_date":"2023-03-16","expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":57042},"source":{"system":"sec-edgar","filing":"0001213900-22-081477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390022081477/ownership.xml","form_type":"4"}},{"id":2255275,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-26T18:43:52.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":182470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of the Company on December 17, 2021, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan (the \"Plan\") increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2022, at the 2022 Annual Meeting of the Company's shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 equal quarterly installments, at 6.25% per quarter, commencing on March 17, 2022."}],"balance_after":300000,"derivative":{"exercise_price":19.03,"exercise_date":"2022-03-17","expiration_date":"2031-12-17","underlying":"Common Stock","underlying_shares":182470},"source":{"system":"sec-edgar","filing":"0001213900-22-029838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390022029838/ownership.xml","form_type":"4"}},{"id":2304452,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2022-04-05T17:34:22.000Z","date":"2022-04-04","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":20500,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-22-018223","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390022018223/ownership.xml","form_type":"4"}},{"id":2304451,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T17:34:22.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":10000,"price":30.0395,"value":300395.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $30.00 to $30.20 per share, inclusive."}],"balance_after":187295,"source":{"system":"sec-edgar","filing":"0001213900-22-018223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390022018223/ownership.xml","form_type":"4"}},{"id":2304450,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T17:34:22.000Z","date":"2022-04-04","kind":"exercise","acquired":true,"shares":10000,"price":3.24,"value":32400.0,"ownership":{"direct":true},"balance_after":197295,"source":{"system":"sec-edgar","filing":"0001213900-22-018223","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390022018223/ownership.xml","form_type":"4"}},{"id":2443949,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2022-01-05T17:01:08.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":30500,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-22-000761","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390022000761/ownership.xml","form_type":"4"}},{"id":2443948,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:01:08.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":20000,"price":3.24,"value":64800.0,"ownership":{"direct":true},"balance_after":187295,"source":{"system":"sec-edgar","filing":"0001213900-22-000761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390022000761/ownership.xml","form_type":"4"}},{"id":2462446,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-21T21:30:42.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":117530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 17, 2022."}],"balance_after":117530,"derivative":{"exercise_price":19.03,"exercise_date":"2022-03-17","expiration_date":"2031-12-17","underlying":"Common Stock","underlying_shares":117530},"source":{"system":"sec-edgar","filing":"0001213900-21-066821","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021066821/ownership.xml","form_type":"4"}},{"id":2794664,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-03-11T17:50:30.000Z","date":"2021-03-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":50500,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001213900-21-014917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021014917/ownership.xml","form_type":"4"}},{"id":2794663,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T17:50:30.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":1612,"price":36.3251,"value":58556.0612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sales prices range from $36.07 to $36.55 per share, inclusive."}],"balance_after":167295,"source":{"system":"sec-edgar","filing":"0001213900-21-014917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021014917/ownership.xml","form_type":"4"}},{"id":2794662,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T17:50:30.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":3388,"price":35.4176,"value":119994.8288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $35.00 to $35.94 per share, inclusive."}],"balance_after":168907,"source":{"system":"sec-edgar","filing":"0001213900-21-014917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021014917/ownership.xml","form_type":"4"}},{"id":2794661,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T17:50:30.000Z","date":"2021-03-09","kind":"exercise","acquired":true,"shares":5000,"price":3.24,"value":16200.0,"ownership":{"direct":true},"balance_after":172295,"source":{"system":"sec-edgar","filing":"0001213900-21-014917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021014917/ownership.xml","form_type":"4"}},{"id":2829732,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-02-26T16:49:39.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":55500,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001213900-21-012171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021012171/ownership.xml","form_type":"4"}},{"id":2829731,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-26T16:49:39.000Z","date":"2021-02-24","kind":"sale","acquired":false,"shares":108,"price":35.5826,"value":3842.9208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sales prices range from $35.49 to $35.59 per share, inclusive."}],"balance_after":167295,"source":{"system":"sec-edgar","filing":"0001213900-21-012171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021012171/ownership.xml","form_type":"4"}},{"id":2829730,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-26T16:49:39.000Z","date":"2021-02-24","kind":"sale","acquired":false,"shares":2463,"price":34.6387,"value":85315.1181,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sales prices range from $34.29 to $35.15 per share, inclusive."}],"balance_after":167403,"source":{"system":"sec-edgar","filing":"0001213900-21-012171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021012171/ownership.xml","form_type":"4"}},{"id":2829729,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-26T16:49:39.000Z","date":"2021-02-24","kind":"sale","acquired":false,"shares":2429,"price":33.6661,"value":81774.9569,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $33.29 to $34.28 per share, inclusive."}],"balance_after":169866,"source":{"system":"sec-edgar","filing":"0001213900-21-012171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021012171/ownership.xml","form_type":"4"}},{"id":2829728,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-26T16:49:39.000Z","date":"2021-02-24","kind":"exercise","acquired":true,"shares":5000,"price":3.24,"value":16200.0,"ownership":{"direct":true},"balance_after":172295,"source":{"system":"sec-edgar","filing":"0001213900-21-012171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021012171/ownership.xml","form_type":"4"}},{"id":2854681,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2021-02-17T18:37:22.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":5000,"price":6,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Warrant was previously reported as covering 100,000 shares of common stock at an exercise price of $1.50 per share, but was adjusted to reflect the stock split that occurred on September 30, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Warrant was previously reported as covering 100,000 shares of common stock at an exercise price of $1.50 per share, but was adjusted to reflect the stock split that occurred on September 30, 2019."}],"balance_after":20000,"derivative":{"exercise_price":6,"exercise_date":"2017-10-04","expiration_date":"2024-10-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001213900-21-010148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021010148/ownership.xml","form_type":"4"}},{"id":2854680,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T18:37:22.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":5000,"price":6,"value":30000.0,"ownership":{"direct":true},"balance_after":167295,"source":{"system":"sec-edgar","filing":"0001213900-21-010148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021010148/ownership.xml","form_type":"4"}},{"id":2869225,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-02-10T19:25:32.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":3569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":60500,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":3569},"source":{"system":"sec-edgar","filing":"0001213900-21-008203","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021008203/ownership.xml","form_type":"4"}},{"id":2869224,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-10T19:25:32.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":2069,"price":35.285,"value":73004.665,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sales prices range from $35.03 to $35.79 per share, inclusive."}],"balance_after":162295,"source":{"system":"sec-edgar","filing":"0001213900-21-008203","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021008203/ownership.xml","form_type":"4"}},{"id":2869223,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-10T19:25:32.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":1500,"price":35.0399,"value":52559.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $35.00 to $35.17 per share, inclusive."}],"balance_after":164364,"source":{"system":"sec-edgar","filing":"0001213900-21-008203","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021008203/ownership.xml","form_type":"4"}},{"id":2869222,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-10T19:25:32.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":3569,"price":3.24,"value":11563.56,"ownership":{"direct":true},"balance_after":165864,"source":{"system":"sec-edgar","filing":"0001213900-21-008203","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021008203/ownership.xml","form_type":"4"}},{"id":2881900,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-02-03T18:34:40.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":2346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":64069,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":2346},"source":{"system":"sec-edgar","filing":"0001213900-21-006570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021006570/ownership.xml","form_type":"4"}},{"id":2881899,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-02-03T18:34:40.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":66415,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-006570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021006570/ownership.xml","form_type":"4"}},{"id":2881898,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T18:34:40.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":2315,"price":35.04,"value":81117.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $35.00 to $35.29 per share, inclusive."}],"balance_after":162295,"source":{"system":"sec-edgar","filing":"0001213900-21-006570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021006570/ownership.xml","form_type":"4"}},{"id":2881897,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T18:34:40.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":31,"price":35,"value":1085.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."}],"balance_after":164610,"source":{"system":"sec-edgar","filing":"0001213900-21-006570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021006570/ownership.xml","form_type":"4"}},{"id":2881896,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T18:34:40.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":2346,"price":3.24,"value":7601.04,"ownership":{"direct":true},"balance_after":164641,"source":{"system":"sec-edgar","filing":"0001213900-21-006570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021006570/ownership.xml","form_type":"4"}},{"id":2881895,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T18:34:40.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":15000,"price":3.24,"value":48600.0,"ownership":{"direct":true},"balance_after":162295,"source":{"system":"sec-edgar","filing":"0001213900-21-006570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021006570/ownership.xml","form_type":"4"}},{"id":2890336,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-01-29T17:20:47.000Z","date":"2021-01-27","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":81415,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001213900-21-005443","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021005443/ownership.xml","form_type":"4"}},{"id":2890335,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-29T17:20:47.000Z","date":"2021-01-27","kind":"sale","acquired":false,"shares":168,"price":33.4,"value":5611.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sales prices range from $33.39 to $33.45 per share, inclusive."}],"balance_after":147295,"source":{"system":"sec-edgar","filing":"0001213900-21-005443","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021005443/ownership.xml","form_type":"4"}},{"id":2890334,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-29T17:20:47.000Z","date":"2021-01-27","kind":"sale","acquired":false,"shares":2988,"price":32.89,"value":98275.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sales prices range from $32.39 to $33.38 per share, inclusive."}],"balance_after":147463,"source":{"system":"sec-edgar","filing":"0001213900-21-005443","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021005443/ownership.xml","form_type":"4"}},{"id":2890333,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-29T17:20:47.000Z","date":"2021-01-27","kind":"sale","acquired":false,"shares":1844,"price":31.69,"value":58436.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $31.30 to $32.29 per share, inclusive."}],"balance_after":150451,"source":{"system":"sec-edgar","filing":"0001213900-21-005443","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021005443/ownership.xml","form_type":"4"}},{"id":2890332,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-29T17:20:47.000Z","date":"2021-01-27","kind":"exercise","acquired":true,"shares":5000,"price":3.24,"value":16200.0,"ownership":{"direct":true},"balance_after":152295,"source":{"system":"sec-edgar","filing":"0001213900-21-005443","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021005443/ownership.xml","form_type":"4"}},{"id":2893502,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-27T06:48:25.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":1800,"price":35.43,"value":63774.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales price range from $35.04 to $35.98 per share, inclusive."}],"balance_after":149580,"source":{"system":"sec-edgar","filing":"0001213900-21-004512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021004512/ownership.xml","form_type":"4/A","original_submission_date":"2021-01-27"}},{"id":2895188,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-01-26T19:30:34.000Z","date":"2021-01-22","kind":"exercise","acquired":false,"shares":4085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":86415,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":3400},"source":{"system":"sec-edgar","filing":"0001213900-21-004482","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021004482/ownership.xml","form_type":"4"}},{"id":2895187,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T19:30:34.000Z","date":"2021-01-26","kind":"sale","acquired":false,"shares":685,"price":35.16,"value":24084.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Sales prices range from $35.00 to $35.75 per share, inclusive."}],"balance_after":147295,"source":{"system":"sec-edgar","filing":"0001213900-21-004482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021004482/ownership.xml","form_type":"4"}},{"id":2895186,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T19:30:34.000Z","date":"2021-01-25","kind":"sale","acquired":false,"shares":1300,"price":35.27,"value":45851.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sales prices range from $35.00 to $35.51 per share, inclusive."}],"balance_after":147980,"source":{"system":"sec-edgar","filing":"0001213900-21-004482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021004482/ownership.xml","form_type":"4"}},{"id":2895185,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T19:30:34.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":300,"price":36.18,"value":10854.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sales prices range from $36.06 to $36.37 per share, inclusive."}],"balance_after":149280,"source":{"system":"sec-edgar","filing":"0001213900-21-004482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021004482/ownership.xml","form_type":"4"}},{"id":2895184,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T19:30:34.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":1800,"price":3543,"value":6377400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sales prices range from $35.04 to $35.98 per share, inclusive."}],"balance_after":149580,"source":{"system":"sec-edgar","filing":"0001213900-21-004482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021004482/ownership.xml","form_type":"4"}},{"id":2895183,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-26T19:30:34.000Z","date":"2021-01-22","kind":"exercise","acquired":true,"shares":4085,"price":3.24,"value":13235.4,"ownership":{"direct":true},"balance_after":151380,"source":{"system":"sec-edgar","filing":"0001213900-21-004482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021004482/ownership.xml","form_type":"4"}},{"id":2911025,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-01-11T16:08:02.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest from the date of grant in quarterly increments of 6.25%."}],"balance_after":150000,"derivative":{"exercise_price":33.43,"exercise_date":"2021-04-07","expiration_date":"2031-01-07","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-21-001421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390021001421/ownership.xml","form_type":"4"}},{"id":3052399,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2020-08-19T16:16:39.000Z","date":"2020-08-18","kind":"exercise","acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period."}],"balance_after":90500,"derivative":{"exercise_price":3.24,"exercise_date":"2017-10-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001213900-20-022888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390020022888/ownership.xml","form_type":"4"}},{"id":3052398,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T16:16:39.000Z","date":"2020-08-18","kind":"tax_withholding","acquired":false,"shares":1826,"price":39.03,"value":71268.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 1,826 shares withheld at the market price of $39.03 per share to fund the cashless exercise of 22,000 options owned by Mr. Kelly, which cashless exercise was approved in advance by the Board of Directors."}],"balance_after":147295,"source":{"system":"sec-edgar","filing":"0001213900-20-022888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390020022888/ownership.xml","form_type":"4"}},{"id":3052397,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T16:16:39.000Z","date":"2020-08-18","kind":"exercise","acquired":true,"shares":22000,"price":3.24,"value":71280.0,"ownership":{"direct":true},"balance_after":149121,"source":{"system":"sec-edgar","filing":"0001213900-20-022888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390020022888/ownership.xml","form_type":"4"}},{"id":3332522,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-12-23T16:56:34.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":150000,"price":43.47,"value":6520500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":43.47,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-19-026855","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019026855/ownership.xml","form_type":"4"}},{"id":3390152,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-21T16:07:46.000Z","date":"2019-10-18","kind":"purchase","acquired":true,"shares":3100,"price":19.2,"value":59520.0,"ownership":{"direct":true},"balance_after":127121,"source":{"system":"sec-edgar","filing":"0001213900-19-020706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019020706/ownership.xml","form_type":"4"}},{"id":3390151,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-21T16:07:46.000Z","date":"2019-10-18","kind":"purchase","acquired":true,"shares":100,"price":19.15,"value":1915.0,"ownership":{"direct":true},"balance_after":124021,"source":{"system":"sec-edgar","filing":"0001213900-19-020706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019020706/ownership.xml","form_type":"4"}},{"id":3390150,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-21T16:07:46.000Z","date":"2019-10-18","kind":"purchase","acquired":true,"shares":200,"price":19.1,"value":3820.0,"ownership":{"direct":true},"balance_after":123921,"source":{"system":"sec-edgar","filing":"0001213900-19-020706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019020706/ownership.xml","form_type":"4"}},{"id":3390149,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-21T16:07:46.000Z","date":"2019-10-18","kind":"purchase","acquired":true,"shares":100,"price":19.08,"value":1908.0,"ownership":{"direct":true},"balance_after":123721,"source":{"system":"sec-edgar","filing":"0001213900-19-020706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019020706/ownership.xml","form_type":"4"}},{"id":3390148,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-21T16:07:46.000Z","date":"2019-10-18","kind":"purchase","acquired":true,"shares":400,"price":19.07,"value":7628.0,"ownership":{"direct":true},"balance_after":123621,"source":{"system":"sec-edgar","filing":"0001213900-19-020706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019020706/ownership.xml","form_type":"4"}},{"id":3390147,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-21T16:07:46.000Z","date":"2019-10-18","kind":"purchase","acquired":true,"shares":100,"price":19.04,"value":1904.0,"ownership":{"direct":true},"balance_after":123221,"source":{"system":"sec-edgar","filing":"0001213900-19-020706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019020706/ownership.xml","form_type":"4"}},{"id":3390146,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-21T16:07:46.000Z","date":"2019-10-18","kind":"purchase","acquired":true,"shares":1000,"price":18.99,"value":18990.0,"ownership":{"direct":true},"balance_after":123121,"source":{"system":"sec-edgar","filing":"0001213900-19-020706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019020706/ownership.xml","form_type":"4"}},{"id":3453266,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-07-30T17:07:12.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":600000,"price":2.2,"value":1320000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":600000,"derivative":{"exercise_price":2.2,"expiration_date":"2029-07-29","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001213900-19-014041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019014041/ownership.xml","form_type":"4"}},{"id":3526071,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2019-05-15T16:07:07.000Z","date":"2019-05-14","kind":"purchase","acquired":true,"shares":50000,"price":2.25,"value":112500.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":2.25,"exercise_date":"2019-05-14","expiration_date":"2024-05-14","underlying":"Common stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-19-008815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019008815/ownership.xml","form_type":"4"}},{"id":3526070,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-15T16:07:07.000Z","date":"2019-05-14","kind":"purchase","acquired":true,"shares":100000,"price":1.5,"value":150000.0,"ownership":{"direct":true},"balance_after":488483,"source":{"system":"sec-edgar","filing":"0001213900-19-008815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390019008815/ownership.xml","form_type":"4"}},{"id":3723354,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-12-20T16:54:37.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":500000,"price":1.15,"value":575000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":500000,"derivative":{"exercise_price":1.15,"expiration_date":"2028-12-20","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-18-017634","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390018017634/ownership.xml","form_type":"4"}},{"id":3735695,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-11T16:21:19.000Z","date":"2018-12-11","kind":"purchase","acquired":true,"shares":5000,"price":1.213,"value":6065.0,"ownership":{"direct":true},"balance_after":388483,"source":{"system":"sec-edgar","filing":"0001213900-18-017210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390018017210/ownership.xml","form_type":"4"}},{"id":3786496,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2018-10-19T13:02:29.000Z","date":"2018-10-12","kind":"purchase","acquired":true,"shares":97500,"price":1.5,"value":146250.0,"ownership":{"direct":true},"balance_after":97500,"derivative":{"exercise_price":1.5,"exercise_date":"2018-10-12","expiration_date":"2023-10-12","underlying":"Common stock","underlying_shares":97500},"source":{"system":"sec-edgar","filing":"0001213900-18-014143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390018014143/ownership.xml","form_type":"4"}},{"id":3786495,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-19T13:02:29.000Z","date":"2018-10-18","kind":"exercise","acquired":true,"shares":223483,"price":0.72,"value":160907.76,"ownership":{"direct":true},"balance_after":383483,"source":{"system":"sec-edgar","filing":"0001213900-18-014143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390018014143/ownership.xml","form_type":"4"}},{"id":3786494,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-19T13:02:29.000Z","date":"2018-10-12","kind":"purchase","acquired":true,"shares":150000,"price":0.9,"value":135000.0,"ownership":{"direct":true},"balance_after":160000,"source":{"system":"sec-edgar","filing":"0001213900-18-014143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390018014143/ownership.xml","form_type":"4"}},{"id":4181886,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2017-10-23T16:38:33.000Z","date":"2017-10-20","kind":"grant","acquired":true,"shares":450000,"price":0.81,"value":364500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":450000,"derivative":{"exercise_price":0.81,"expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001213900-17-010833","document":"f4101917kelly_relmada.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390017010833/f4101917kelly_relmada.xml","form_type":"4"}},{"id":4190243,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2017-10-06T11:10:14.000Z","date":"2017-10-04","kind":"purchase","acquired":true,"shares":100000,"price":1.5,"value":150000.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":1.5,"exercise_date":"2017-10-04","expiration_date":"2024-10-04","underlying":"Common stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-17-010350","document":"f4100417kelly_relmadatherap.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390017010350/f4100417kelly_relmadatherap.xml","form_type":"4"}},{"id":4190242,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71428,"kind":"person","name":"Kelly Paul Edward","position":1,"cik":"0001658544","reported_name":"Kelly Paul Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2017-10-06T11:10:14.000Z","date":"2017-10-04","kind":"purchase","acquired":true,"shares":200000,"price":0.75,"value":150000.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.75,"exercise_date":"2017-10-04","expiration_date":"2019-10-04","underlying":"Common stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-17-010350","document":"f4100417kelly_relmadatherap.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658544/000121390017010350/f4100417kelly_relmadatherap.xml","form_type":"4"}}]}